What a week on "Squawk Box"! Bill Ackman teams up with Valeant to buy Botox-maker Allergan. Novartis' buying and selling and lil' Squawkers running the show.
April 24- Aetna Inc said on Thursday its first few months under Obamacare turned out better than expected as it added new members not only on the exchanges but in its traditional large corporate business.
The "Fast Money" traders share their final trades of the day.
Some of Thursday's midday movers:
April 17- UnitedHealth Group Inc, the largest U.S. health insurer, said on Thursday it has spent more than $100 million to cover a pricey new hepatitis C drug from Gilead Sciences Inc, a higher cost than it expected by "multiples," sending shares in the sector lower.
Does your portfolio leave you feeling a little nauseous? Cramer thinks shares of Aetna could make you feel a lot better.
March 21- U.S. lawmakers have asked Gilead Sciences Inc to explain the $84,000 price tag of its new hepatitis C drug Sovaldi, which is encountering resistance from health insurers and state Medicaid programs. Biogen Idec fell 8 percent, Amgen Inc dropped 3 percent and Celgene Corp lost 3.7 percent.
March 21- U.S. lawmakers have asked Gilead Sciences Inc to explain the $84,000 price tag of its new hepatitis C drug Sovaldi, which is encountering resistance from health insurers and state Medicaid programs. Biogen Idec fell 6 percent, Amgen Inc dropped 2.5 percent and Celgene Corp was down 2 percent.
*Nike falls after results, Tiffany rises. Geopolitical issues remained in focus after President Vladimir Putin signed laws completing Russia's annexation of Crimea and investors took fright at a U.S. decision to slap sanctions on his inner circle.
*Nike shares fall in premarket after outlook. NEW YORK, March 21- U.S. stock index futures pointed to a slightly higher open on Friday, with major indexes on track for a week of strong gains, though geopolitical concerns remained in view as the tenuous situation in Ukraine continued.
*Nike shares fall in premarket after outlook. NEW YORK, March 21- U.S. stock index futures edged higher on Friday, with major indexes on track for a week of strong gains, though geopolitical concerns remained in view as the tenuous situation in Ukraine continued.
Some of the names on the move ahead of the open.
As Americans rush to sign up for Obamacare plans before the March 31 deadline, investors have turned bullish on health insurers.
NEW YORK, March 6- Shopping for employee health insurance on private marketplaces might be the way of the future for tens of millions. However, expert opinions about growth have been based on projections, not actual consumer behavior in the exchanges that only really got going last year.
Several insurers, including Molina Healthcare, which administer health plans for California's Medicaid program for the poor are asking states to step in and pay for Gilead Sciences Inc's Sovaldi, a drug that costs $84,000 per patient.
With stocks near all-time highs, short interest reached the highest level in 20 months, but some investors are seeing the trend as a bullish sign.
Some of Monday's midday movers:
Humana shares surged more than 7 percent Monday after it said proposed health department rate cuts may be more benign than anticipated.
Feb 7- Cigna Corp on Friday said costs in its private Medicare business were higher than expected in the fourth quarter and might continue on that path in 2014, resulting in a disappointing outlook and pushing its shares down nearly 9 percent.
Feb 6- Aetna Inc, the third-largest U.S. health insurer, said on Thursday it expects to lose money on the Obamacare exchanges even as demand for these insurance plans has picked up over the past few weeks.